# A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)

> **NCT03505892** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 28 (actual)

## Conditions studied

- Ankylosing Spondylitis (AS)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03505892
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-05
- **Primary completion:** 2021-10-25
- **Final completion:** 2021-10-25
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03505892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03505892, "A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03505892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*